Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
8.55
+0.24 (2.89%)
At close: Dec 5, 2025, 4:00 PM EST
8.46
-0.09 (-1.05%)
After-hours: Dec 5, 2025, 7:57 PM EST
Nuvation Bio Revenue
Nuvation Bio had revenue of $13.12M in the quarter ending September 30, 2025, with 1,704.68% growth. This brings the company's revenue in the last twelve months to $26.75M, up 1,137.19% year-over-year. In the year 2024, Nuvation Bio had annual revenue of $7.87M.
Revenue (ttm)
$26.75M
Revenue Growth
+1,137.19%
P/S Ratio
108.62
Revenue / Employee
$121,582
Employees
220
Market Cap
2.93B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NUVB News
- 3 days ago - Nuvation Bio Inc. (NUVB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 days ago - Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology - Business Wire
- 7 days ago - Nuvation Bio: A Strong Company Now Fairly Priced - Seeking Alpha
- 9 days ago - Nuvation Bio to Participate in Upcoming Investor Conferences - Business Wire
- 14 days ago - Nuvation Bio Inc. (NUVB) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Nuvation Bio: Ibtrozi's Rollout So Far Confirms Bullish Case - Seeking Alpha
- 4 weeks ago - Nuvation Bio Inc. (NUVB) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire